This is not just another drug safety conference — it is a unique opportunity to hear personal experiences from leading professionals dedicated to Pharmacovigilance and patient safety worldwide. Experts will share insights on today’s evolving PV challenges, best practices for integrating disruptive technologies, and strategies to maintain regulatory compliance even with limited budgets.

Key topics include prioritization in PV, advanced therapy methodologies, the role of AI in signal detection, and preparing the future PV workforce, from Gen Z entrants to seasoned industry veterans. Additional discussions will focus on innovation, outsourcing, regulatory updates, real-world evidence (RWE) data use, and public engagement.

The conference features visionary keynotes, case studies, and panel discussions, offering diverse expert perspectives on critical issues in Pharmacovigilance and drug safety. Attendees also benefit from structured and informal networking opportunities, fostering meaningful collaborations and knowledge exchange.

This event unites professionals under one mission: bringing safer medicines to patients faster, more efficiently, and sustainably.

9 June 2026 — 10 June 2026
2:40 pm

Venue to be announced Basel

Link to the conference